Müller-Esterl W - Search Results

1

Probing human beta1- and beta2 -adrenoceptors with domain-specific fusion protein antibodies.

Jahns R, Siegmund C, Jahns V, Reiländer H, Maidhof A, Müller-Esterl W, Lohse MJ, Boege F. Jahns R, et al. Eur J Pharmacol. 1997 Sep 3;334(1):115-26. doi: 10.1016/s0014-2999(97)80346-9. Eur J Pharmacol. 1997. PMID: 9346338

2

Probing human beta 1- and beta 2-adrenoceptors with domain-specific fusion protein antibodies.

Jahns R, Siegmund C, Jahns V, Reiländer H, Maidhof A, Müller-Esterl W, Lohse MJ, Boege F. Jahns R, et al. Eur J Pharmacol. 1996 Nov 28;316(1):111-21. doi: 10.1016/s0014-2999(96)00654-1. Eur J Pharmacol. 1996. PMID: 8982658

3

Structural features of the human bradykinin B2 receptor probed by agonists, antagonists, and anti-idiotypic antibodies.

Alla SA, Buschko J, Quitterer U, Maidhof A, Haasemann M, Breipohl G, Knolle J, Müller-Esterl W. Alla SA, et al. J Biol Chem. 1993 Aug 15;268(23):17277-85. J Biol Chem. 1993. PMID: 8394337 Free article.

4

Extracellular domains of the bradykinin B2 receptor involved in ligand binding and agonist sensing defined by anti-peptide antibodies.

Alla SA, Quitterer U, Grigoriev S, Maidhof A, Haasemann M, Jarnagin K, Müller-Esterl W. Alla SA, et al. J Biol Chem. 1996 Jan 19;271(3):1748-55. doi: 10.1074/jbc.271.3.1748. J Biol Chem. 1996. PMID: 8576178 Free article.

5

Ligand-induced phosphorylation/dephosphorylation of the endogenous bradykinin B2 receptor from human fibroblasts.

Blaukat A, Alla SA, Lohse MJ, Müller-Esterl W. Blaukat A, et al. J Biol Chem. 1996 Dec 13;271(50):32366-74. doi: 10.1074/jbc.271.50.32366. J Biol Chem. 1996. PMID: 8943300 Free article.

6

On the structure of the amino-terminal domain ED1 of the B2 receptor.

Abd Alla S, Quitterer U, Schröder C, Blaukat A, Horstmeyer A, Dedio J, Reiländer H, Müller-Esterl W. Abd Alla S, et al. Immunopharmacology. 1996 Jun;33(1-3):42-5. doi: 10.1016/0162-3109(96)00082-3. Immunopharmacology. 1996. PMID: 8856113 No abstract available.

7

On the structure of the amino-terminal domain ED1 of the B2 receptor.

Abd Alla S, Quitterer U, Schröder C, Blaukat A, Horstmeyer A, Dedio J, Reiländer H, Müller-Esterl W. Abd Alla S, et al. Immunopharmacology. 1996 Oct;35(1):23-6. doi: 10.1016/0162-3109(96)00129-4. Immunopharmacology. 1996. PMID: 8913791 No abstract available.

8

Anti-idiotypic antibodies against the kinin receptor.

Haasemann M, Buschko J, Faussner A, Roscher AA, Hoebeke J, Burch R, Müller-Esterl W. Haasemann M, et al. J Cardiovasc Pharmacol. 1992;20 Suppl 9:S47-54. J Cardiovasc Pharmacol. 1992. PMID: 1282630

9

Downregulation of bradykinin B2 receptor in human fibroblasts during prolonged agonist exposure.

Blaukat A, Micke P, Kalatskaya I, Faussner A, Müller-Esterl W. Blaukat A, et al. Am J Physiol Heart Circ Physiol. 2003 Jun;284(6):H1909-16. doi: 10.1152/ajpheart.00034.2003. Am J Physiol Heart Circ Physiol. 2003. PMID: 12742822 Free article.

10

An NMR study of the interaction of 15N-labelled bradykinin with an antibody mimic of the bradykinin B2 receptor.

Ottleben H, Haasemann M, Ramachandran R, Görlach M, Müller-Esterl W, Brown LR. Ottleben H, et al. Eur J Biochem. 1997 Mar 1;244(2):471-8. doi: 10.1111/j.1432-1033.1997.00471.x. Eur J Biochem. 1997. PMID: 9119014 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters